Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| NELNET INCNNI · Entity 3982 | Director | June 21, 2021 | June 22, 2021 |
| NRC HEALTHNRC · Entity 5534 | Director | June 29, 2021 | July 01, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
NELNET INC
Report date June 21, 2021 · Filed June 22, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 6,132 |
Reported balance
After 2021-06-21 transaction · row 1
1 source rowRow 1 · 2021-06-21 · Grant · Acquired 2,450 · Balance 6,132 F1: These shares were granted pursuant to the issuer's Directors Stock Compensation Plan. |
Filing footnotes · ownership attribution and instrument terms
F1: These shares were granted pursuant to the issuer's Directors Stock Compensation Plan.
NRC HEALTH
Report date June 29, 2021 · Filed July 01, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Director Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $46.32 · Expires 2031-06-29 | Direct | 7,289 |
Reported balance
After 2021-06-29 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2021-06-29 · Grant · Acquired 7,289 · Balance 7,289 F1: This award is an annual grant to the reporting person made under the Issuer's 2004 Non-Employee Director Stock Plan (the "Plan") on the date of the Issuer's 2021 annual shareholder meeting. In accordance with the terms of the Plan, the award will vest and become exercisable on the date immediately preceding the date of the Issuer's next annual shareholder meeting, subject to certain exceptions provided in the Plan. |
Filing footnotes · ownership attribution and instrument terms
F1: This award is an annual grant to the reporting person made under the Issuer's 2004 Non-Employee Director Stock Plan (the "Plan") on the date of the Issuer's 2021 annual shareholder meeting. In accordance with the terms of the Plan, the award will vest and become exercisable on the date immediately preceding the date of the Issuer's next annual shareholder meeting, subject to certain exceptions provided in the Plan.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 29, 2021 Filed Jul 1, 2021 20:52 UTC | NRC HEALTH NRC · Entity 5534 | GrantDirector Stock Option (Right to Buy) · Derivative | 7,289 | $0.00 Strike: $46.32 | $0.00 |
DisclosureSEC source: 0001567619-21-012855 · doc1.xml · derivative · entry 1 MARTIN JOANN M · CIK 0001248113 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,289 Underlying: Common Stock · 7,289 shares Expires 2031-06-29 F1 · derivative.exercise_date: This award is an annual grant to the reporting person made under the Issuer's 2004 Non-Employee Director Stock Plan (the "Plan") on the date of the Issuer's 2021 annual shareholder meeting. In accordance with the terms of the Plan, the award will vest and become exercisable on the date immediately preceding the date of the Issuer's next annual shareholder meeting, subject to certain exceptions provided in the Plan. Read SEC document |
| June 21, 2021 Filed Jun 22, 2021 20:40 UTC | NELNET INC NNI · Entity 3982 | GrantClass A Common Stock | 2,450 | $63.28 | $155,036.00 |
DisclosureSEC source: 0001437749-21-015390 · rdgdoc.xml · nonDerivative · entry 1 MARTIN JOANN M · CIK 0001248113 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,132 F1 · shares: These shares were granted pursuant to the issuer's Directors Stock Compensation Plan. Read SEC document |
| February 12, 2021 Filed Feb 16, 2021 21:05 UTC | NRC HEALTH NRC · Entity 5534 | SaleCommon Stock | 5,000 | $50.66 | $253,300.00 |
DisclosureSEC source: 0001567619-21-004001 · doc1.xml · nonDerivative · entry 2 MARTIN JOANN M · CIK 0001248113 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 138,955 Read SEC document |
| January 08, 2021 Filed Feb 16, 2021 21:05 UTC | NRC HEALTH NRC · Entity 5534 | GiftCommon Stock | 28,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-21-004001 · doc1.xml · nonDerivative · entry 1 MARTIN JOANN M · CIK 0001248113 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 143,955 Read SEC document |
| December 29, 2020 Filed Feb 11, 2021 21:35 UTC | NRC HEALTH NRC · Entity 5534 | GiftCommon Stock | 69,953 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-21-003087 · doc1.xml · nonDerivative · entry 2 MARTIN JOANN M · CIK 0001248113 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 171,955 Read SEC document |
| December 28, 2020 Filed Feb 11, 2021 21:35 UTC | NRC HEALTH NRC · Entity 5534 | GiftCommon Stock | 69,953 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-21-003087 · doc1.xml · nonDerivative · entry 1 MARTIN JOANN M · CIK 0001248113 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 241,908 Read SEC document |
| November 18, 2020 Filed Nov 20, 2020 21:02 UTC | NRC HEALTH NRC · Entity 5534 | Exercise / conversionDirecto Stock Option (Right to Buy) · Derivative | 36,000 | $0.00 Strike: $14.19 | $0.00 |
DisclosureSEC source: 0001567619-20-020162 · doc1.xml · derivative · entry 7 MARTIN JOANN M · CIK 0001248113 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 36,000 shares Expires 2026-05-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 18, 2020 Filed Nov 20, 2020 21:02 UTC | NRC HEALTH NRC · Entity 5534 | Exercise / conversionDirector Stock Option (Right to Buy) · Derivative | 36,000 | $0.00 Strike: $14.95 | $0.00 |
DisclosureSEC source: 0001567619-20-020162 · doc1.xml · derivative · entry 6 MARTIN JOANN M · CIK 0001248113 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 36,000 shares Expires 2024-05-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 18, 2020 Filed Nov 20, 2020 21:02 UTC | NRC HEALTH NRC · Entity 5534 | Exercise / conversionDirector Stock Option (Right to Buy) · Derivative | 36,000 | $0.00 Strike: $16.89 | $0.00 |
DisclosureSEC source: 0001567619-20-020162 · doc1.xml · derivative · entry 5 MARTIN JOANN M · CIK 0001248113 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 36,000 shares Expires 2023-05-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 18, 2020 Filed Nov 20, 2020 21:02 UTC | NRC HEALTH NRC · Entity 5534 | Tax withholdingCommon Stock | 29,948 | $55.33 | $1,657,022.84 |
DisclosureSEC source: 0001567619-20-020162 · doc1.xml · nonDerivative · entry 4 MARTIN JOANN M · CIK 0001248113 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 311,862 Read SEC document |
| November 18, 2020 Filed Nov 20, 2020 21:02 UTC | NRC HEALTH NRC · Entity 5534 | Exercise / conversionCommon Stock | 36,000 | $14.19 | $510,840.00 |
DisclosureSEC source: 0001567619-20-020162 · doc1.xml · nonDerivative · entry 3 MARTIN JOANN M · CIK 0001248113 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 341,810 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 18, 2020 Filed Nov 20, 2020 21:02 UTC | NRC HEALTH NRC · Entity 5534 | Exercise / conversionCommon Stock | 36,000 | $14.95 | $538,200.00 |
DisclosureSEC source: 0001567619-20-020162 · doc1.xml · nonDerivative · entry 2 MARTIN JOANN M · CIK 0001248113 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 305,810 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 18, 2020 Filed Nov 20, 2020 21:02 UTC | NRC HEALTH NRC · Entity 5534 | Exercise / conversionCommon Stock | 36,000 | $16.89 | $608,040.00 |
DisclosureSEC source: 0001567619-20-020162 · doc1.xml · nonDerivative · entry 1 MARTIN JOANN M · CIK 0001248113 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 269,810 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 18, 2020 Filed Nov 25, 2020 22:50 UTC Amendment | NRC HEALTH NRC · Entity 5534 | Tax withholdingCommon Stock | 29,949 | $55.33 | $1,657,078.17 |
DisclosureSEC source: 0001567619-20-020392 · doc1.xml · nonDerivative · entry 1 MARTIN JOANN M · CIK 0001248113 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 311,861 F1 · shares: The original Form 4 is being amended to correct an administrative error by increasing the number of shares forfeited in the reported transaction by one share and correspondingly decreasing the number of shares beneficially owned by the reporting person by one share. Read SEC document |
| November 16, 2020 Filed Nov 18, 2020 21:19 UTC | NRC HEALTH NRC · Entity 5534 | SaleCommon Stock | 36,000 | $55.17 | $1,986,253.20 |
DisclosureSEC source: 0001567619-20-020023 · doc1.xml · nonDerivative · entry 1 MARTIN JOANN M · CIK 0001248113 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 233,810 F1 · price: The price in Column 4 is a weighted average price. The prices actually received ranged from $55.00 to $55.87, inclusive. The reporting person has provided to the issuer, and will provide to any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within this range. Read SEC document |
| September 21, 2020 Filed Sep 23, 2020 20:30 UTC | NRC HEALTH NRC · Entity 5534 | Exercise / conversionDirector Stock Option (Right to Buy) · Derivative | 36,000 | $0.00 Strike: $14.21 | $0.00 |
DisclosureSEC source: 0001567619-20-017050 · doc1.xml · derivative · entry 5 MARTIN JOANN M · CIK 0001248113 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 36,000 shares Expires 2025-05-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 21, 2020 Filed Sep 23, 2020 20:30 UTC | NRC HEALTH NRC · Entity 5534 | Tax withholdingCommon Stock | 10,729 | $47.68 | $511,558.72 |
DisclosureSEC source: 0001567619-20-017050 · doc1.xml · nonDerivative · entry 4 MARTIN JOANN M · CIK 0001248113 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 269,810 Read SEC document |
| September 21, 2020 Filed Sep 23, 2020 20:30 UTC | NRC HEALTH NRC · Entity 5534 | Exercise / conversionCommon Stock | 36,000 | $14.21 | $511,560.00 |
DisclosureSEC source: 0001567619-20-017050 · doc1.xml · nonDerivative · entry 3 MARTIN JOANN M · CIK 0001248113 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 280,539 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 02, 2020 Filed Sep 23, 2020 20:30 UTC | NRC HEALTH NRC · Entity 5534 | GiftCommon Stock | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-20-017050 · doc1.xml · nonDerivative · entry 2 MARTIN JOANN M · CIK 0001248113 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 244,539 Read SEC document |
| August 12, 2020 Filed Sep 23, 2020 20:30 UTC | NRC HEALTH NRC · Entity 5534 | GiftCommon Stock | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-20-017050 · doc1.xml · nonDerivative · entry 1 MARTIN JOANN M · CIK 0001248113 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 249,539 Read SEC document |
| July 23, 2020 Filed Jul 27, 2020 20:38 UTC | NRC HEALTH NRC · Entity 5534 | SaleCommon Stock | 19,853 | $60.00 | $1,191,180.00 |
DisclosureSEC source: 0001567619-20-013764 · doc1.xml · nonDerivative · entry 1 MARTIN JOANN M · CIK 0001248113 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 254,539 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F1 · acquired: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| July 17, 2020 Filed Jul 21, 2020 20:23 UTC | NRC HEALTH NRC · Entity 5534 | SaleCommon Stock | 110 | $60.00 | $6,600.00 |
DisclosureSEC source: 0001567619-20-013532 · doc1.xml · nonDerivative · entry 1 MARTIN JOANN M · CIK 0001248113 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 274,392 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F1 · acquired: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| July 15, 2020 Filed Jul 17, 2020 20:10 UTC | NRC HEALTH NRC · Entity 5534 | SaleCommon Stock | 14 | $60.00 | $840.00 |
DisclosureSEC source: 0001567619-20-013423 · doc1.xml · nonDerivative · entry 2 MARTIN JOANN M · CIK 0001248113 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 274,502 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F1 · acquired: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| June 19, 2020 Filed Jun 23, 2020 20:34 UTC | NELNET INC NNI · Entity 3982 | GrantClass A Common Stock | 3,226 | $40.30 | $130,007.80 |
DisclosureSEC source: 0001437749-20-013665 · rdgdoc.xml · nonDerivative · entry 1 MARTIN JOANN M · CIK 0001248113 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,682 F1 · shares: These shares were granted pursuant to the issuer's Directors Stock Compensation Plan. Read SEC document |
| June 11, 2020 Filed Jul 17, 2020 20:10 UTC | NRC HEALTH NRC · Entity 5534 | GiftCommon Stock | 500 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-20-013423 · doc1.xml · nonDerivative · entry 1 MARTIN JOANN M · CIK 0001248113 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 274,516 Read SEC document |
| June 05, 2020 Filed Jun 9, 2020 21:59 UTC | NRC HEALTH NRC · Entity 5534 | SaleCommon Stock | 23 | $60.00 | $1,380.00 |
DisclosureSEC source: 0001567619-20-011913 · doc1.xml · nonDerivative · entry 1 MARTIN JOANN M · CIK 0001248113 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 275,016 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F1 · acquired: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| May 18, 2020 Filed May 20, 2020 20:39 UTC | NRC HEALTH NRC · Entity 5534 | GrantDirector Stock Option (Right to Buy) · Derivative | 7,179 | $0.00 Strike: $54.11 | $0.00 |
DisclosureSEC source: 0001567619-20-010827 · doc1.xml · derivative · entry 1 MARTIN JOANN M · CIK 0001248113 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,179 Underlying: Common Stock · 7,179 shares Expires 2030-05-18 F1 · derivative.exercise_date: This award is an annual grant to the reporting person made under the Issuer's 2004 Non-Employee Director Stock Plan (the "Plan") on the date of the Issuer's 2020 annual shareholder meeting. In accordance with the terms of the Plan, the award will vest and become exercisable on the date immediately preceding the date of the Issuer's next annual shareholder meeting, subject to certain exceptions provided in the Plan. Read SEC document |
| March 19, 2020 Filed Mar 23, 2020 20:50 UTC | NELNET INC NNI · Entity 3982 | GrantClass A Common Stock | 456 | $36.58 | $16,680.48 |
DisclosureSEC source: 0001437749-20-005917 · rdgdoc.xml · nonDerivative · entry 1 MARTIN JOANN M · CIK 0001248113 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 456 F1 · shares: These shares were granted pursuant to the issuer's Directors Stock Compensation Plan. Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 21:49 UTC | NRC HEALTH NRC · Entity 5534 | Exercise / conversionDirector Stock Option (Right to Buy) · Derivative | 36,000 | $0.00 Strike: $13.81 | $0.00 |
DisclosureSEC source: 0001567619-20-005463 · doc1.xml · derivative · entry 5 MARTIN JOANN M · CIK 0001248113 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 36,000 shares Expires 2022-05-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 21:49 UTC | NRC HEALTH NRC · Entity 5534 | Exercise / conversionDirector Stock Option (Right to Buy) · Derivative | 36,000 | $0.00 Strike: $9.74 | $0.00 |
DisclosureSEC source: 0001567619-20-005463 · doc1.xml · derivative · entry 4 MARTIN JOANN M · CIK 0001248113 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 36,000 shares Expires 2021-05-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 21:49 UTC | NRC HEALTH NRC · Entity 5534 | Tax withholdingCommon Stock | 15,416 | $54.99 | $847,725.84 |
DisclosureSEC source: 0001567619-20-005463 · doc1.xml · nonDerivative · entry 3 MARTIN JOANN M · CIK 0001248113 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 275,039 Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 21:49 UTC | NRC HEALTH NRC · Entity 5534 | Exercise / conversionCommon Stock | 36,000 | $13.81 | $497,160.00 |
DisclosureSEC source: 0001567619-20-005463 · doc1.xml · nonDerivative · entry 2 MARTIN JOANN M · CIK 0001248113 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 290,455 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 21:49 UTC | NRC HEALTH NRC · Entity 5534 | Exercise / conversionCommon Stock | 36,000 | $9.74 | $350,640.00 |
DisclosureSEC source: 0001567619-20-005463 · doc1.xml · nonDerivative · entry 1 MARTIN JOANN M · CIK 0001248113 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 254,455 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 29, 2019 Filed Jun 5, 2019 21:45 UTC | NRC HEALTH NRC · Entity 5534 | GrantDirector Stock Option (Right to Buy) · Derivative | 6,821 | $0.00 Strike: $50.62 | $0.00 |
DisclosureSEC source: 0001567619-19-012841 · doc1.xml · derivative · entry 2 MARTIN JOANN M · CIK 0001248113 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,821 Underlying: Common Stock · 6,821 shares Expires 2029-05-29 Read SEC document |
| May 30, 2018 Filed Jan 22, 2019 22:59 UTC | NRC HEALTH NRC · Entity 5534 | GrantDirector Stock Option (Right to Buy) · Derivative | 10,440 | $0.00 Strike: $34.90 | $0.00 |
DisclosureSEC source: 0001567619-19-001449 · doc1.xml · derivative · entry 2 MARTIN JOANN M · CIK 0001248113 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,440 Underlying: Common Stock · 10,440 shares Expires 2028-05-30 Read SEC document |
| April 17, 2018 Filed Apr 18, 2018 21:50 UTC | NRC HEALTH NRCIA/B · Entity 5534 | Disposition to issuerDirector Stock Option (Right to Buy) · Derivative | 6,000 | Not disclosed Strike: $44.47 | Not disclosed |
DisclosureSEC source: 0001140361-18-018966 · doc1.xml · derivative · entry 9 MARTIN JOANN M · CIK 0001248113 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class B Common Stock · 6,000 shares Expires 2027-05-09 F2 · price: Pursuant to the Recapitalization, all outstanding options to purchase class B common stock were vested in full and cancelled. In exchange for the option, the reporting person received one share of common stock, plus $19.59 in cash for each class B option, less the exercise price per share of the option. F2 · derivative.exercise_date: Pursuant to the Recapitalization, all outstanding options to purchase class B common stock were vested in full and cancelled. In exchange for the option, the reporting person received one share of common stock, plus $19.59 in cash for each class B option, less the exercise price per share of the option. Read SEC document |
| April 17, 2018 Filed Apr 18, 2018 21:50 UTC | NRC HEALTH NRCIA/B · Entity 5534 | Disposition to issuerDirector Stock Option (Right to Buy) · Derivative | 6,000 | Not disclosed Strike: $37.78 | Not disclosed |
DisclosureSEC source: 0001140361-18-018966 · doc1.xml · derivative · entry 8 MARTIN JOANN M · CIK 0001248113 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class B Common Stock · 6,000 shares Expires 2026-05-11 F2 · price: Pursuant to the Recapitalization, all outstanding options to purchase class B common stock were vested in full and cancelled. In exchange for the option, the reporting person received one share of common stock, plus $19.59 in cash for each class B option, less the exercise price per share of the option. F2 · derivative.exercise_date: Pursuant to the Recapitalization, all outstanding options to purchase class B common stock were vested in full and cancelled. In exchange for the option, the reporting person received one share of common stock, plus $19.59 in cash for each class B option, less the exercise price per share of the option. Read SEC document |
| April 17, 2018 Filed Apr 18, 2018 21:50 UTC | NRC HEALTH NRCIA/B · Entity 5534 | Disposition to issuerDirector Stock Option (Right to Buy) · Derivative | 6,000 | Not disclosed Strike: $34.50 | Not disclosed |
DisclosureSEC source: 0001140361-18-018966 · doc1.xml · derivative · entry 7 MARTIN JOANN M · CIK 0001248113 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class B Common Stock · 6,000 shares Expires 2025-05-07 F2 · price: Pursuant to the Recapitalization, all outstanding options to purchase class B common stock were vested in full and cancelled. In exchange for the option, the reporting person received one share of common stock, plus $19.59 in cash for each class B option, less the exercise price per share of the option. F2 · derivative.exercise_date: Pursuant to the Recapitalization, all outstanding options to purchase class B common stock were vested in full and cancelled. In exchange for the option, the reporting person received one share of common stock, plus $19.59 in cash for each class B option, less the exercise price per share of the option. Read SEC document |
| April 17, 2018 Filed Apr 18, 2018 21:50 UTC | NRC HEALTH NRCIA/B · Entity 5534 | Disposition to issuerDirector Stock Option (Right to Buy) · Derivative | 6,000 | Not disclosed Strike: $43.91 | Not disclosed |
DisclosureSEC source: 0001140361-18-018966 · doc1.xml · derivative · entry 6 MARTIN JOANN M · CIK 0001248113 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class B Common Stock · 6,000 shares Expires 2024-05-08 F2 · price: Pursuant to the Recapitalization, all outstanding options to purchase class B common stock were vested in full and cancelled. In exchange for the option, the reporting person received one share of common stock, plus $19.59 in cash for each class B option, less the exercise price per share of the option. F2 · derivative.exercise_date: Pursuant to the Recapitalization, all outstanding options to purchase class B common stock were vested in full and cancelled. In exchange for the option, the reporting person received one share of common stock, plus $19.59 in cash for each class B option, less the exercise price per share of the option. Read SEC document |
| April 17, 2018 Filed Apr 18, 2018 21:50 UTC | NRC HEALTH NRCIA/B · Entity 5534 | Disposition to issuerDirector Stock Option (Right to Buy) · Derivative | 6,000 | Not disclosed Strike: $30.72 | Not disclosed |
DisclosureSEC source: 0001140361-18-018966 · doc1.xml · derivative · entry 5 MARTIN JOANN M · CIK 0001248113 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class B Common Stock · 6,000 shares Expires 2023-05-09 F2 · price: Pursuant to the Recapitalization, all outstanding options to purchase class B common stock were vested in full and cancelled. In exchange for the option, the reporting person received one share of common stock, plus $19.59 in cash for each class B option, less the exercise price per share of the option. F2 · derivative.exercise_date: Pursuant to the Recapitalization, all outstanding options to purchase class B common stock were vested in full and cancelled. In exchange for the option, the reporting person received one share of common stock, plus $19.59 in cash for each class B option, less the exercise price per share of the option. Read SEC document |
| April 17, 2018 Filed Apr 18, 2018 21:50 UTC | NRC HEALTH NRCIA/B · Entity 5534 | Disposition to issuerDirector Stock Option (Right to Buy) · Derivative | 6,000 | Not disclosed Strike: $26.10 | Not disclosed |
DisclosureSEC source: 0001140361-18-018966 · doc1.xml · derivative · entry 4 MARTIN JOANN M · CIK 0001248113 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class B Common Stock · 6,000 shares Expires 2022-05-11 F2 · price: Pursuant to the Recapitalization, all outstanding options to purchase class B common stock were vested in full and cancelled. In exchange for the option, the reporting person received one share of common stock, plus $19.59 in cash for each class B option, less the exercise price per share of the option. F2 · derivative.exercise_date: Pursuant to the Recapitalization, all outstanding options to purchase class B common stock were vested in full and cancelled. In exchange for the option, the reporting person received one share of common stock, plus $19.59 in cash for each class B option, less the exercise price per share of the option. Read SEC document |
| April 17, 2018 Filed Apr 18, 2018 21:50 UTC | NRC HEALTH NRCIA/B · Entity 5534 | GrantCommon Stock | 11,446 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-18-018966 · doc1.xml · nonDerivative · entry 3 MARTIN JOANN M · CIK 0001248113 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 218,455 F1 · security: On April 17, 2018, the Issuer completed a recapitalization whereby the Issuer exchanged one share of its then-existing class A common stock, plus $19.59 in cash, without interest, for each share of its then-existing class B common stock and, following such exchange, each share of class A common stock was reclassified as a share of Common Stock (the "Recapitalization"). F2 · kind: Pursuant to the Recapitalization, all outstanding options to purchase class B common stock were vested in full and cancelled. In exchange for the option, the reporting person received one share of common stock, plus $19.59 in cash for each class B option, less the exercise price per share of the option. F2 · price: Pursuant to the Recapitalization, all outstanding options to purchase class B common stock were vested in full and cancelled. In exchange for the option, the reporting person received one share of common stock, plus $19.59 in cash for each class B option, less the exercise price per share of the option. Read SEC document |
| April 17, 2018 Filed Apr 18, 2018 21:50 UTC | NRC HEALTH NRCIA/B · Entity 5534 | GrantCommon Stock | 31,733 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-18-018966 · doc1.xml · nonDerivative · entry 2 MARTIN JOANN M · CIK 0001248113 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 207,009 F1 · security: On April 17, 2018, the Issuer completed a recapitalization whereby the Issuer exchanged one share of its then-existing class A common stock, plus $19.59 in cash, without interest, for each share of its then-existing class B common stock and, following such exchange, each share of class A common stock was reclassified as a share of Common Stock (the "Recapitalization"). F1 · kind: On April 17, 2018, the Issuer completed a recapitalization whereby the Issuer exchanged one share of its then-existing class A common stock, plus $19.59 in cash, without interest, for each share of its then-existing class B common stock and, following such exchange, each share of class A common stock was reclassified as a share of Common Stock (the "Recapitalization"). F1 · price: On April 17, 2018, the Issuer completed a recapitalization whereby the Issuer exchanged one share of its then-existing class A common stock, plus $19.59 in cash, without interest, for each share of its then-existing class B common stock and, following such exchange, each share of class A common stock was reclassified as a share of Common Stock (the "Recapitalization"). Read SEC document |
| April 17, 2018 Filed Apr 18, 2018 21:50 UTC | NRC HEALTH NRCIA/B · Entity 5534 | Disposition to issuerClass B Common Stock | 31,733 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-18-018966 · doc1.xml · nonDerivative · entry 1 MARTIN JOANN M · CIK 0001248113 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: On April 17, 2018, the Issuer completed a recapitalization whereby the Issuer exchanged one share of its then-existing class A common stock, plus $19.59 in cash, without interest, for each share of its then-existing class B common stock and, following such exchange, each share of class A common stock was reclassified as a share of Common Stock (the "Recapitalization"). F1 · price: On April 17, 2018, the Issuer completed a recapitalization whereby the Issuer exchanged one share of its then-existing class A common stock, plus $19.59 in cash, without interest, for each share of its then-existing class B common stock and, following such exchange, each share of class A common stock was reclassified as a share of Common Stock (the "Recapitalization"). Read SEC document |
| May 09, 2017 Filed May 11, 2017 16:23 UTC | NRC HEALTH NRCIA/B · Entity 5534 | GrantDirector Stock Option (Right to Buy) · Derivative | 6,000 | $0.00 Strike: $44.47 | $0.00 |
DisclosureSEC source: 0001140361-17-019555 · doc1.xml · derivative · entry 3 MARTIN JOANN M · CIK 0001248113 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,000 Underlying: Class B Common Stock · 6,000 shares Expires 2027-05-09 Read SEC document |
| May 09, 2017 Filed May 11, 2017 16:23 UTC | NRC HEALTH NRCIA/B · Entity 5534 | GrantDirector Stock Option (Right to Buy) · Derivative | 36,000 | $0.00 Strike: $24.35 | $0.00 |
DisclosureSEC source: 0001140361-17-019555 · doc1.xml · derivative · entry 2 MARTIN JOANN M · CIK 0001248113 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,000 Underlying: Class A Common Stock · 36,000 shares Expires 2027-05-09 Read SEC document |
| April 26, 2017 Filed Apr 28, 2017 15:32 UTC | NRC HEALTH NRCIA/B · Entity 5534 | Exercise / conversionDirector Stock Option (Right to Buy) · Derivative | 13,800 | $0.00 Strike: $8.49 | $0.00 |
DisclosureSEC source: 0001140361-17-017276 · doc1.xml · derivative · entry 3 MARTIN JOANN M · CIK 0001248113 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 13,800 shares Expires 2018-05-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 26, 2017 Filed Apr 28, 2017 15:32 UTC | NRC HEALTH NRCIA/B · Entity 5534 | Tax withholdingClass A Common Stock | 4,772 | $24.55 | $117,152.60 |
DisclosureSEC source: 0001140361-17-017276 · doc1.xml · nonDerivative · entry 2 MARTIN JOANN M · CIK 0001248113 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 175,276 F1 · kind: Reflects payment of option exercise expense. Read SEC document |
| April 26, 2017 Filed Apr 28, 2017 15:32 UTC | NRC HEALTH NRCIA/B · Entity 5534 | Exercise / conversionClass A Common Stock | 13,800 | $8.49 | $117,162.00 |
DisclosureSEC source: 0001140361-17-017276 · doc1.xml · nonDerivative · entry 1 MARTIN JOANN M · CIK 0001248113 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 180,048 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.